Is Enovix an Underrated Small Cap?
Enovix (NASDAQ:ENVX) is one of several small, innovative companies hoping…
Sell
34
SUPN Quote, Financials, Valuation and Earnings
Last price:
$32.11
Seasonality move
:
11.77%
Day range:
$31.22 - $32.22
52-week range:
$25.53 - $40.28
Dividend yield:
0%
P/E ratio:
28.56x
P/S ratio:
2.66x
P/B ratio:
1.72x
Volume:
474.2K
Avg. volume:
518.4K
1-year change:
5.67%
Market cap:
$1.8B
Revenue:
$661.8M
EPS (TTM):
$1.11
Supernus Pharmaceuticals SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
SUPN
Supernus Pharmaceuticals
|
05/08/2024 | 10-Q | 10-Q filing on 05/08/2024 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
11/08/2023 | 10-Q | 10-Q filing on 11/08/2023 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
08/08/2023 | 10-Q | 10-Q filing on 08/08/2023 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
05/09/2023 | 10-Q | 10-Q filing on 05/09/2023 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
11/09/2022 | 10-Q | 10-Q filing on 11/09/2022 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
08/08/2022 | 10-Q | 10-Q filing on 08/08/2022 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
05/12/2022 | 10-Q | 10-Q filing on 05/12/2022 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
11/05/2021 | 10-Q | 10-Q filing on 11/05/2021 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
08/06/2021 | 10-Q | 10-Q filing on 08/06/2021 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
05/07/2021 | 10-Q | 10-Q filing on 05/07/2021 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
11/06/2020 | 10-Q | 10-Q filing on 11/06/2020 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
08/17/2020 | 10-Q | 10-Q filing on 08/17/2020 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
05/15/2020 | 10-Q | 10-Q filing on 05/15/2020 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
02/28/2020 | 10-K | 10-K filing on 02/28/2020 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
11/08/2019 | 10-Q | 10-Q filing on 11/08/2019 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
08/09/2019 | 10-Q | 10-Q filing on 08/09/2019 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
05/10/2019 | 10-Q | 10-Q filing on 05/10/2019 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
03/01/2019 | 10-K | 10-K filing on 03/01/2019 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
11/09/2018 | 10-Q | 10-Q filing on 11/09/2018 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
08/09/2018 | 10-Q | 10-Q filing on 08/09/2018 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
05/10/2018 | 10-Q | 10-Q filing on 05/10/2018 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
03/01/2018 | 10-K | 10-K filing on 03/01/2018 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
11/09/2017 | 10-Q | 10-Q filing on 11/09/2017 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
08/03/2017 | 10-Q | 10-Q filing on 08/03/2017 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
05/09/2017 | 10-Q | 10-Q filing on 05/09/2017 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
03/16/2017 | 10-K | 10-K filing on 03/16/2017 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
01/23/2017 | 10-Q | 10-Q filing on 01/23/2017 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
01/20/2017 | 10-Q | 10-Q filing on 01/20/2017 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
01/20/2017 | 10-K | 10-K filing on 01/20/2017 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
08/05/2016 | 10-Q | 10-Q filing on 08/05/2016 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
05/10/2016 | 10-Q | 10-Q filing on 05/10/2016 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
03/09/2016 | 10-K | 10-K filing on 03/09/2016 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
11/09/2015 | 10-Q | 10-Q filing on 11/09/2015 | View Form |
|
SUPN
Supernus Pharmaceuticals
|
08/07/2015 | 10-Q | 10-Q filing on 08/07/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Are We Heading Toward a Recession?
Fears of a recession in 2025 grew at the end…
3 Recession-Proof ETFs to Invest in Now
The U.S. gross domestic product (GDP) contracted 0.3% during the…
Stock Ideas
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 12
Regencell Bioscience Holdings [RGC] is up 28.41% over the past day.
Buy
97
NGVC alert for May 12
Natural Grocers by Vitamin Cottage [NGVC] is down 11.01% over the past day.
Sell
38
ONTO alert for May 12
Onto Innovation [ONTO] is up 4.36% over the past day.
